[The treatment of acute mycotic colpitis with ciclopiroxolamine in patients using oral contraceptives].
The author reveal the results of treatment with ciclopiroxolamine of women suffering from mycotic colpitis and using OC's. The research covers 26 women users of monophasic OC's with mycotic colpitis during the last 2-3 weeks before the research. The cause for the colpitis in 92% of cases is Candida albicans. The treatment was successful in 84.6% of the cases after the first 6-day-course with Batrafen creme. With 7.7% the treatment course with Batrafen creme was repeated, and with another 7.7% was included oral antimycotic (itraconazol). After treatment was performed microbiological check-up that confirmed the positive result of treatment. The authors' conclusion is that Batrafen creme is an effective device suitable for application on patients, CO's users.
Damianov
L
L
Novachkov
V
V
Ivanov
S
S
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D000077768:Ciclopirox; D003276:Contraceptives, Oral; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use*; D014622:Vaginal Creams, Foams, and Jellies / Q000627:therapeutic use*
D000935:Antifungal Agents; D003276:Contraceptives, Oral; D011728:Pyridones; D014622:Vaginal Creams, Foams, and Jellies; D000077768:Ciclopirox; D017964:Itraconazole